12 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $1.2B | -$167M | 39.5% | 35.9% | $274M | — | $78M |
| 2024 | $1.2B | -$430M | 38.7% | 35.5% | $51M | — | $68M |
| 2023 | $1.2B | -$5M | 36.6% | 34.8% | $95M | — | $96M |
| 2022 | $1.7B | $212M | 34.2% | 27.1% | $171M | — | $77M |
| 2021 | $1.4B | $118M | 36.9% | 30.3% | $190M | — | $275M |
| 2020 | $1.2B | $181M | 38.3% | 32.7% | $270M | $1.3B | $258M |
| 2019 | $1.3B | $184M | 37.3% | 30.7% | $161M | $1.3B | $57M |
| 2018 | $1.1B | $169M | 36.8% | 28.3% | $158M | $759M | $78M |
| 2017 | $972M | $127M | 33.8% | 25.0% | $122M | $455M | $88M |
| 2016 | $908M | $35M | 30.2% | 18.0% | $71M | $492M | $31M |
| 2015 | — | $80M | — | — | -$29M | — | $32M |
| 2014 | — | $129M | — | — | $37M | — | $20M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $258M | $60M | 45.1% | 0.0% | -$12M | — | $95M |
| Dec '25 | $255M | -$85M | 34.4% | 0.0% | $74M | — | $78M |
| Sep '25 | $333M | $44M | 40.2% | 0.0% | $118M | — | $83M |
| Jun '25 | $365M | -$147M | 37.8% | 0.0% | $67M | — | $77M |
| Mar '25 | $248M | $21M | 45.1% | 0.0% | $15M | — | $72M |
| Dec '24 | $263M | $17M | 37.9% | 30.6% | $40M | — | $68M |
| Sep '24 | $334M | -$107M | 39.4% | 33.0% | $29M | — | $136M |
| Jun '24 | $391M | -$284M | 31.5% | 25.9% | $12M | — | $107M |
| Mar '24 | $340M | -$56M | 29.3% | 22.6% | -$29M | — | $89M |
| Dec '23 | $372M | -$117M | 16.0% | 16.6% | $17M | — | $96M |
| Sep '23 | $446M | $25M | 28.9% | 24.8% | $72M | — | $85M |
| Jun '23 | $482M | $36M | 31.8% | 25.1% | $27M | — | $68M |
| Mar '23 | $393M | $51M | 33.2% | 26.5% | -$20M | — | $78M |
| Dec '22 | $384M | $16M | 27.5% | 19.4% | $49M | — | $77M |
| Sep '22 | $482M | $75M | 36.6% | 28.7% | $64M | — | $72M |
| Jun '22 | $420M | $60M | 35.9% | 28.8% | $61M | — | $131M |
| Mar '22 | $383M | $61M | 36.0% | 31.1% | -$3M | — | $223M |
| Dec '21 | $336M | $29M | 31.3% | 23.7% | $39M | — | $275M |
| Sep '21 | $377M | -$4M | 37.6% | 31.7% | $75M | — | $269M |
| Jun '21 | $358M | $44M | 39.0% | 32.8% | $42M | — | $233M |
How the market has priced NGVT against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Ingevity Corp's revenue has declined 0.8% per year. These are computed facts, not advice.
As of FY2025, Ingevity Corp reported — of total debt against $78M of cash; operating income covered interest expense 5.3×.
In FY2025, gross margin was 39.5%, operating margin 35.9%, and net margin -14.3%.
As of Jun '26, Ingevity Corp traded at a price-to-earnings ratio of about 7.8× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.